Cerevance

Boston, United States

Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases.

$47.0M raised

May 2026

Series C

Top Investors

Dementia Discovery FundForesite CapitalTakedaSV Health InvestorsLightstone Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Cerevance raised?

Cerevance has raised $47.0M in total funding. The most recent round was Series C. The last funding was announced in May 2026.

Who are Cerevance's investors?

Cerevance's investors include Dementia Discovery Fund, Foresite Capital, Takeda, SV Health Investors, Lightstone Ventures.

Where is Cerevance headquartered?

Cerevance is headquartered in Boston, United States.

What does Cerevance do?

Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases.

What stage is Cerevance at?

Cerevance is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 12, 2026.

MLA

"Cerevance — Funding & Investors." VCBacked, May 12, 2026, https://www.vcbacked.co/company/cerevance. Accessed June 4, 2026.

APA

VCBacked. (2026). Cerevance — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/cerevance

Wikipedia (cite web)

{{cite web |title=Cerevance — Funding & Investors |url=https://www.vcbacked.co/company/cerevance |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 12, 2026.